TENON MEDICAL INC TNON
ASignal's systematic analysis rates TNON as Bearish.
Reflects the latest available analysis · analyzed Oct 11, 2026
The case on TNON
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong revenue growth (126.8% YoY)
- High gross margin (66.81%) indicates pricing power
- Positive free cash flow trend not confirmed but improving from deep negative
- MACD histogram expanding above signal line suggesting momentum shift
- Negative profit and operating margins
- Negative return on equity (-551.19%) and return on assets (-71.98%)
- Current ratio (0.58x) and quick ratio (0.44x) indicate liquidity risk
- High debt levels relative to cash position
- Only one news source (Benzinga), limited news coverage
- No Reddit mentions, low retail investor interest
See the full verdict on TNON
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes TNON
Most investors never get a second opinion, let alone several. ASignal runs TNON past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.